secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001683168-23-006511
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical stockholders approve reverse stock split of 1:8 to 1:12
-----------------------------------------------------------------------

- Reverse stock split approved by 6,781,311 for, 2,180,424 against; Board to set ratio and effective date by Oct 5, 2023.
- All six director nominees elected: Broenniman, Cipriani, Fisher, Gikakis, Rossetti, Shah.
- Baker Tilly US ratified as independent auditor for fiscal 2024 with 8,177,582 for, 562,051 against.
- Voter turnout 36.29% (9,012,954 of 24,835,321 shares present).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316823006511/0001683168-23-006511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316823006511/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-006511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer